Cerebral Therapeutics, Inc. — Form D
Cerebral Therapeutics, Inc. of AURORA, CO, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-25. The offering totals $7.0M, of which $2.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-06-25
- Form: D
- Accession: 0001209191-18-039416
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $2.5M
- Remaining: $4.5M
- Investors: 2
- Date of first sale: 2018-06-11
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-315333
Issuer
- Name: Cerebral Therapeutics, Inc.
- CIK: 0001744709
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 12635 E. MONTVIEW BLVD., AURORA, CO, 80045
- Phone: 3035473448
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Daniel Abrams | Director | Boston, MA |
| Daniel Abrams | Executive Officer | Boston, MA |
| Weston Nichols | Director | Dorado, PR |
| Matthew Hammond | Director | VANCOUVER, A1 |
| Mahendra Shah | Director | Palo Alto, CA |
| Stephen Farr | Director | South San Francisco, CA |
| Warren Lammert | Director | Seattle, WA |
| Shah Mahendra | Director | Palo Alto, CA |
Other filings by this issuer (3)
More